SCHEMBL4808166

SCHEMBL4808166

COc1nc(S(C)(=O)=O)nc(-c2ccc(Cl)cc2Cl)c1S(=O)(=O)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 6/20 0.39
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
HPGD P15428 4/20 0.35
NPSR1 Q6W5P4 4/20 0.35
KDM4E B2RXH2 3/20 0.35
LMNA P02545 3/20 0.35
HTT P42858 2/20 0.35
MITF O75030 1/20 0.35
STAT3 P40763 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
TP53 P04637 2/20 0.34
KMT2A Q03164 2/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
DPP4 P27487 4/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4801796 0.80 CRHR1 (0.42) CRHR1GSK3AGSK3BDYRK1ACLK4
SCHEMBL4807572 0.79 CNR1 (0.44) CRHR1DPP4CNR1CNR2
SCHEMBL4804699 0.78 CNR1 (0.42) CRHR1GSK3AGSK3BDYRK1ACLK4
SCHEMBL4808908 0.77 CNR1 (0.42) CRHR1GSK3AGSK3BDYRK1ACLK4
SCHEMBL14107174 0.77 CRHR1 (0.35) CRHR1GSK3AGSK3BDYRK1ACLK4
SCHEMBL14107173 0.76 ABCB11 (0.41) CRHR1GSK3AGSK3BDYRK1ACLK4
SCHEMBL14107165 0.74 CYP3A4 (0.35) CRHR1HPGDNPSR1KDM4ELMNA
SCHEMBL4801271 0.70 CNR1 (0.44) CRHR1HPGDNPSR1KDM4EKMT2A
SCHEMBL14107166 0.70 CRHR1 (0.40) CRHR1HPGDNPSR1KDM4EDPP4
SCHEMBL4801340 0.69 CNR1 (0.52) CRHR1HPGDNPSR1KDM4ECNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405221-B2 Substituted pyrimidines MERCK & CO., INC. (US) 2008-07-29 US disclosed
US-20050245554-A1 Substituted pyrimidines MERCK SHARP & DOHME CORP. 2005-11-03 US disclosed
EP-1546115-A2 SUBSTITUTED PYRIMIDINES Merck & Co., Inc. (US) 2005-06-29 EP disclosed
WO-2004029204-A2 SUBSTITUTED PYRIMIDINES MERCK & CO., INC. (US) 2004-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245554-A1 Substituted pyrimidines CNR1, CNR2, GPR119 CRHR1 233/4885GSK3A 1632/4885GSK3B 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.